Biography of Matthew Frankel

Last update: 24 days ago

Career

Matthew was Vice President, Clinical Development and Medical Affairs, Specialty Care at Boehringer Ingelheim, and Vice President and Head of Immunology and Dermatology Medical Unit at Novartis. Matthew Frankel joined Chemomab in 2022.

Matthew Frankel is currently Chief Medical Officer and Vice President of Drug Development at Chemomab - View - Chemomab org chart

Create your alert
to follow the career of Matthew Frankel.

Education

Matthew Frankel has a Doctor of Medicine from University of California, Los Angeles and a Master of Business Administration in finance and marketing from Northwestern University - Kellogg School of Management.

They have also studied at University of California, Los Angeles :

Find more alumni from University of California, Los Angeles


They have also studied at Northwestern University - Kellogg School of Management :

Find more alumni from Northwestern University - Kellogg School of Management

The colleagues of Matthew Frankel

Company Colleagues
Homonyms
Industry Colleagues
  • In the Biotechnology industry, Matthew Frankel has 30,257 colleagues in 2,282 companies located in 40 countries. 14,390 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Matthew Frankel.

Get in Touch

Sorry, but Matthew Frankel cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of Matthew Frankel listed below. Here are a few tips for establishing great contacts.

With Skype, Call Chemomab at +972 77... and ask for Matthew Frankel.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.